Genmab
Differentiated human antibody therapeutics for the treatment of cancer. Learn more
Launch date
Employees
Market cap
CAD22.7b
Enterprise valuation
CAD19.8b (Public information from Sep 2024)
Share price
DKK2491 GMAB
Company register number 21023884
Copenhagen Capital Region of Denmark (HQ)
Authorizing premium user...